Finn Haadem • 1955 • Oslo • 11 roles • 9 shareholdings

This website uses cookies to enhance the user experience.

Roles

Management

Name	Role	Total operating income	Total equity	Shares
H HAADEM INVEST AS	Managing Director/CEO	-	86,885,200	20 % directly
S SOLLI2 AS	Managing Director/CEO	-	-	-

Boards

Name	Role	Total operating income	Total equity	Shares
H HAADEM INVEST AS	Chairman	-	86,885,200	20 % directly
V VERNIX PHARMA AS	Contact Person	-	199,540	2.79 % indirectly
N NANOPOWER SEMICONDUCTOR AS	Deputy Chair	-3,507	29,976,733	1.86 % indirectly
V VINKLUBBEN VIN & VILT	Board Member	-	-	-
L LADESSA AS	Alternate Member	-	1,187,537	-
S SWEET HOME ANS	Contact Person	-	-	-
S SOLLI2 AS	Chairman	-	-	-

Last update: Jan 17, 2024

Related industries5

Direct relationships5

BE
Brita Eilertsen1962
VERNIX PHARMA AS, LADESSA AS, SWEET HOME ANS, HAADEM INVEST AS
ØE
Øystein Erling Tvenge1955
VINKLUBBEN VIN & VILT, VERNIX PHARMA AS
TB
Thomas Berntsen1970
NANOPOWER SEMICONDUCTOR AS
AR
Aril Resen1965
SOLLI2 AS
OH
Odd Harald Hauge1956
NANOPOWER SEMICONDUCTOR AS

Shares owned by Finn Haadem

Name	Share class	Total operating income	Total equity	Share
H HAADEM INVEST AS	A-aksjer	0	86,885,200	20 % directly
B BØDALEN UTVIKLING AS		0	-620,112	4 % indirectly
V VERNIX PHARMA AS		0	199,540	2.79 % indirectly
N NANOPOWER SEMICONDUCTOR AS		-3,507	29,976,733	1.86 % indirectly
H HAXTHAUSEN MILJØTUN AS		0	-3,481,307	1.3 % indirectly
F FRAM CLIMATE AS		0	1,733,695	1.2 % indirectly
G GUMØY GOLF AS	Ordinære aksjer	2,067,343	3,065,524	0.45 % directly < 0.01 %
E ENSURGE MICROPOWER ASA	NO0012450008	0	-57,682,000	0.37 % directly 0.37 % indirectly 0.26 %
N NYKODE THERAPEUTICS ASA	NO0010714785	13,362,000	174,832,000	0.02 % directly < 0.01 %

Limited to direct ownership positions of 0.5% or more.

Last update: May 24, 2024